← Product Code [GEX](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX) · K162765 # Venus Velocity Diode Laser System (K162765) _Venus Concept , Ltd. · GEX · Jan 11, 2017 · General, Plastic Surgery · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K162765 ## Device Facts - **Applicant:** Venus Concept , Ltd. - **Product Code:** [GEX](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX.md) - **Decision Date:** Jan 11, 2017 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 878.4810 - **Device Class:** Class 2 - **Review Panel:** General, Plastic Surgery - **Attributes:** Therapeutic ## Intended Use The Venus Velocity is intended for all Fitzpatrick skin types, including tanned skin, for use in dermatology, general and plastic surgery applications for: - Hair removal; - Permanent hair reduction (defined as the long-term stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen); and - Treatment of pseudofolliculitis barbae. ## Device Story Venus Velocity is a diode laser system for hair removal and treatment of pseudofolliculitis barbae. Device consists of a console and a detachable diode laser applicator with interchangeable sapphire light guides. System uses a water-cooling pump to regulate handpiece/tip temperature, minimizing patient discomfort and burn risk. Operated by clinicians in dermatology or plastic surgery settings. Clinician selects energy parameters via software interface; laser energy is delivered to the skin to target hair follicles. Safety features include emergency stop, user authentication, and software-controlled energy output limits. Benefits include permanent hair reduction and treatment of skin conditions associated with hair growth. Device performance is verified through electrical safety, electromagnetic compatibility, and biocompatibility testing. ## Clinical Evidence Bench testing only. Includes electromagnetic compatibility and electrical safety testing per IEC 60601-1, IEC 60601-1-2, IEC 60601-2-22, and IEC 60825-1. Biocompatibility of patient-contacting materials confirmed per ISO 10993-1 and ISO 10993-5. Software verification and validation performed. System verification confirmed energy outputs meet specifications. ## Technological Characteristics Diode laser system; console with water-cooling pump; detachable applicator; interchangeable sapphire light guides (small, medium, large). Energy source: diode laser. Safety features: emergency stop, user login/password, software-controlled energy limits. Biocompatible materials per ISO 10993. Electrical/EMC compliance per IEC 60601 series. ## Regulatory Identification (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon. ## Predicate Devices - Palomar Vectus Laser ([K120622](/device/K120622.md)) - Lumenis Ltd. LightSheer® Desire ([K151947](/device/K151947.md)) ## Reference Devices - Alma Lasers Modified Diode Laser Module with SHR Treatment Mode for use with the Family of Soprano XL Multi-Application Platforms ([K112031](/device/K112031.md)) - Sandstone Medical's Cheveux Diode Laser System ([K100893](/device/K100893.md)) - Milesman's Milesman Premium ([K073300](/device/K073300.md)) - ILOODA Company's Vikini ([K151232](/device/K151232.md)) - Beijing Anchorfree Technology's Diode Laser Hair Removal System ([K141973](/device/K141973.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with three curved lines above them. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 January 11, 2017 Venus Concept Ltd. % Janice Hogan Regulatory Counsel Hogan Lovells US LLP 1835 Market St., 29th Floor Philadelphia, Pennsylvania 19103 Re: K162765 Trade/Device Name: Venus Velocity Regulation Number: 21 CFR 878.4810 Regulation Name: Laser Surgical Instrument for Use In General And Plastic Surgery and In Dermatology Regulatory Class: Class II Product Code: GEX Dated: November 29, 2016 Received: November 29, 2016 Dear Ms. Hogan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR {1}------------------------------------------------ Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely, # Jennifer R. Stevenson -A For Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ 510(k) Number (if known) K162765 Device Name Venus Velocity Indications for Use (Describe) The Venus Velocity is intended for all Fitzpatrick skin types, including tanned skin, for use in dermatology, general and plastic surgery applications for: - Hair removal: - Permanent hair reduction (defined as the long-term stable reduction in the number of hairs regrowing when ● measured at 6, 9, and 12 months after the completion of a treatment regimen); and - Treatment of pseudofolliculitis barbae. Type of Use (Select one or both, as applicable) 区 Prescription Use (Part 21 CFR 801 Subpart D) _ Over-The-Counter Use (21 CFR 801 Subpart C) #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ #### 510(k) SUMMARY ## Venus Concept Ltd.'s Venus Velocity ## Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared Venus Concept Ltd. 4556 N. Hiatus Road Sunrise, FL 33351 Phone: 416.907.0115 Facsimile: 954.572.5680 Contact Person: Tal Bresler-Stramer, Ph.D., RAC, Vice President, QA/RA Date Prepared: November 29, 2016 ## Name of Device and Classification/Product Code Trade/Proprietary Name: Venus Velocity Common or Usual Name: Diode laser system Classification Name: 21 C.F.R. § 878.4810, Laser surgical instrument for use in general and plastic surgery and in dermatology Product Code: GEX # Predicate and Reference Devices Predicate Devices: Palomar Medical Technologies, Inc.'s Palomar Vectus Laser (K120622); Lumenis Ltd. LightSheer® Desire (K151947) Reference Devices: Alma Lasers Modified Diode Laser Module with SHR Treatment Mode for use with the Family of Soprano XL Multi-Application Platforms (K112031): Sandstone Medical's Cheveux Diode Laser System (K100893); Milesman's Milesman Premium (K073300); ILOODA Company's Vikini (K151232); Beijing Anchorfree Technology's Diode Laser Hair Removal System (K141973). # Intended Use / Indications for Use The Venus Velocity is intended for all Fitzpatrick skin types, including tanned skin, for use in dermatology, general and plastic surgery applications for: - Hair removal; - o Permanent hair reduction (defined as the long-term stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen); and - . Treatment of pseudofolliculitis barbae. # Technological Characteristics The Venus Velocity consists of a console, a detachable diode laser applicator, and three interchangeable sapphire light quides/tips (small, medium, and large sizes). A water system and {4}------------------------------------------------ pump in the console distribute water to cool the handpiece and tips during device use, decreasing the likelihood of burns, discomfort, or pain during treatment. The system is also provided with a water filling kit. The device incorporates several safety features, including an emergency laser stop button, user login and password protection, and other software and hardware settings to mitigate the risk of improper energy release and ensure that system outputs are within specifications. The device also comes with goggles and patient eye protectors. ## Performance Data Performance testing of the subject device supports its safety and effectiveness profile for the proposed indications. Electromagnetic compatibility and electrical safety testing was conducted per IEC 60601-1, IEC 60601-1-2, IEC 60601-2-22, and IEC 60825-1. All results were passing. In addition, the patient-contacting materials are biocompatible per ISO 10993-1 and ISO 10993-5. The Venus Velocity also underwent software verification and validation, with results demonstrating that the software is appropriate for release. System verification testing further confirmed that the system performs as intended, and that the energy outputs of the device meet specifications. # Substantial Equivalence The Venus Velocity has the same intended uses and similar indications, technological characteristics, and principles of operation as its predicate devices, the Palomar Vectus and Lumenis LightSheer Desire laser systems. The minor technological differences between the Venus Velocity and its predicates raise no new issues of safety or effectiveness. The key energy parameters are very similar for the devices, where the available wavelength, spot sizes, pulse durations, fluence outputs, and peak power for the Venus Velocity are within the ranges previously cleared for the predicates. In addition, the higher frequency available with the Venus Velocity does not raise different questions of safety or effectiveness because other laser-based devices for similar indications have also been cleared with the same 10 Hz maximum frequency. Performance data demonstrate that the Venus Velocity performs as intended, and further support that the device performs as intended. Thus, the Venus Velocity is substantially equivalent to its predicates. # Conclusions The tests outlined above demonstrate that the device performs as intended. The Venus Velocity has the same intended uses and similar indications, technological characteristics, and principles of operation as its predicate devices. Minor differences between the subject and predicate devices do not present any new or different types of safety or effectiveness questions. In sum, the Venus Velocity is substantially equivalent to its predicate devices. --- **Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K162765](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K162765) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com